DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

Business Affairs Homepage

Survey finds medical devices not meeting provider expectations A call for higher-quality clinical evidence, flexible contract options and better customer service

European Society of Radiology calls for diagnostics to be better represented in value-based care Diagnosis 'is the basis for any treatment decision'

GE Healthcare receives Carequality certification Centricity customers can share data among multiple providers

Canon elaborates on financial goals with Toshiba Medical in the fold 'Launching into the global health market ... in one fell swoop'

Former Cleveland Clinic Innovations director pleads guilty to fraud Scheme cost the institution over $2.7 million

NuVasive files lawsuit against former vice chairman Alleges breach of fiduciary duties and violation of contractual obligations

Blue Earth Diagnostics inks Axumin deal with Seibersdorf Laboratories Manufacturing and distribution in certain European countries

Philips to halt production of external defibrillators in two U.S. facilities OEM looks ahead, calling consent decree 'consequence of past sins'

2017 AARC Congress: Focus on COPD For four days in Indianapolis, patients took center stage

Amazon may decide to sell prescription drugs online by Thanksgiving Supply chain and regulatory hurdles could make it more trouble than it's worth

Procedure with Profound's
TULSA-PRO system

Philips completes sale of MR-HIFU business to Profound Medical

by Lauren Dubinsky , Senior Reporter
Royal Philips announced today that it completed its business deal with Profound Medical Corporation.

Last month, the companies entered an asset and share purchase agreement. Profound agreed to acquire Philips' MR-Guided High Intensity Focused Ultrasound business in exchange for 7,400,000 Profound common shares.

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras



"We see a world where patients no longer need to choose between living well and living long, or between undergoing clinically effective procedures and returning quickly to their normal lives," Dr. Arun Menawat, CEO of Profound Medical, told HCB News. "By leveraging MR-guidance and ultrasound to deliver incision-free, inherently safe, personalizable, precise and cost-effective therapeutic solutions, we believe that we are well on our way toward realizing that vision."

Philips' Sonalleve MR-HIFU is used along with real-time MR imaging and thermometry to noninvasively ablate diseased tissue. To date, it has CE mark for the treatment of uterine fibroids and palliative pain associated with bone metastases.

Philips will continue to distribute Sonalleve for use with its Ingenia and Achieva MR systems. The company will also provide Profound with additional services such as manufacturing the MR-HIFU table and installations.

"The addition of Sonalleve to our offering benefits hospital customers by providing them with the ability to better utilize their MR system assets," said Menawat. "Our strengthened MR and ultrasound technology platform will accelerate the development of new clinical applications, while better serving the needs of our customers."

Philips is already a non-exclusive distributor of Profound's TULSA-PRO system and will continue to be. This system is designed for MR-guided prostate tissue ablation procedures.

Profound is now the only company that provides a therapeutics platform that combines real-time MR imaging and directional and focused ultrasound technology for ablating diseased tissue.

As part of the business agreement, Philips can purchase or sell securities of Profound "from time to time as it deems appropriate, based on market conditions and other circumstances."

However, Philips agreed not to sell, transfer or dispose of its interest in the common shares for one year after the completion of the transaction.

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED